Medical Education Grants
A Boehringer Ingelheim Pharmaceutical Inc. medical education grant is designed to support independent medical education for healthcare providers and patients that may translate to better management of disease and improvement in patient safety and population health.
Please see below for submission timelines:
- Grant applications with total program budgets of $10,000.00 or less, must be submitted no less than 60 days prior to the program start date.
- Grant applications with total program budgets greater than $10,000.00, must be submitted no less than 90 days prior to the program start date.
Learn About the Medical Education Grants Process
New and returning visitors are encouraged to explore an
online tutorial about the Medical Education Grants application process. Visitors seeking Medical Grant support in the
Endocrine Diabetes Disease State will be considered under the Boehringer Ingelheim Pharmaceutical Inc (BIPI) and Eli Lilly and Company (Lilly) global alliance agreement.
To begin the process of applying for a Medical Education grant within the Endocrine Diabetes Disease State, click here.
New and Returning Visitors to Boehringer Ingelheim Pharmaceuticals, Inc. Medical Grants
For new visitors to begin a new application, login at
https://bipisupport.envisionpharma.com/vt_bi/#Login to register as a New User. Returning visitors, please login at
https://bipisupport.envisionpharma.com/vt_bi/#Login, to start an application, return to a saved application, or track the status of an application already submitted. An application ID beginning with "ME", will be assigned once you submit the application.
Therapeutic Areas of Interest
Learn about the
specific areas of interest in consideration for our funding.
Responding to a Request for Educational Grant Application (REGA)
Throughout the year, the Medical Grants department will announce a Request for Educational Grant Application (REGA). The intent of this announcement is to notify experienced and accredited Continuing Medical Education (CME) providers and accredited Continuing Education (CE) providers that BI is interested in receiving applications for educational grants for support consideration.
Grant applications in response to REGAs need to be submitted online at https://bipisupport.envisionpharma.com/vt_bi/#Login. While REGAs may specify timing of requested responses, Boehringer Ingelheim Pharmaceuticals, Inc. will continue to review all grant requests which are received. To contact Boehringer Ingelheim Pharmaceuticals, Inc. Medical Grants Department, please call (800) 295-0717. (8:00 a.m. - 5:00 p.m. EST, Monday – Friday).
